News

When you're investing for the long term, it can sometimes pay to buy beaten-down stocks that have fallen into disfavor. Companies being hit by a slew of bad news aren't necessarily doomed to fail

Coming into 2020, there's no question that you would have been better off investing in Regeneron Pharmaceuticals (NASDAQ: REGN) than in CVS (NYSE: CVS). If you had spent $10,000 on each stock at the

I own shares of about 40 different stocks between my retirement accounts and standard (taxable) brokerage accounts. Over the years, I've owned and sold dozens more. Of all of them, I can't think of

For many investors, 2020 has tested their investing resolves like never before. The coronavirus disease 2019 (COVID-19) pandemic has whipsawed equities over a six-month span, leading to the fastest

Gilead Sciences (NASDAQ: GILD) navigated the coronavirus market crash better than most. At one point, the biotech's antiviral drug, Veklury (remdesivir), was considered one of the most promising

There is currently bipartisan support in the U.S. within both the House and Senate for some form of coronavirus relief package, including a second round of stimulus checks expected to be worth

The S&P 500 just hit a fresh all-time high, meaning that the effects of the COVID-19 pandemic on the overall stock market have been erased. However, the financial sector has lagged behind. Although

It wasn't a stretch to conclude that a pandemic would wreak havoc on daily life for many Americans. But how many people would have guessed that it would give birth to an entire new class of newbie

When the coronavirus pandemic led state and local governments to issue stay-at-home mandates earlier this year, gyms and other workout facilities were among those that had to shut their doors. But

High dividend yields aren't always a great thing for investors. In fact, a high yield is often a sign that the market thinks the dividend is at risk and likely coming down, especially if it's out of

Visa (NYSE: V) is an iconic financial services brand, but the company wasn't spared when the COVID-19 pandemic sent the global economy spiraling. Visa makes money by charging fees to merchants when

Shares of Datadog (NASDAQ: DDOG), MercadoLibre (NASDAQ: MELI), and Cloudflare (NYSE: NET) have more than doubled in 2020. These stocks have seen more opportunities than challenges in the coronavirus

It's been a crazy year for the Dow Jones Industrials (DJINDICES: ^DJI). The COVID-19 pandemic brought the average its first severe bear market in over a decade, and just as abruptly, the average

The COVID-19 crisis has certainly done a number on the U.S. economy, plunging it deep into recession territory. Many people worry that things will stay dire well into 2021, and possibly even beyond.

Following a huge run-up in its stock price that sent shares from $21.50 at the beginning of the year to levels as high as $117.79 in early August, shares of edge computing company Fastly (NYSE:

Retirement should be one of the best times in your life. But older Americans face some substantial risks -- and if you aren't prepared for them, they could turn your later years into a stressful

Few stocks have delivered returns as impressive as Vaxart (NASDAQ: VXRT) so far in 2020. The vaccine maker's shares skyrocketed more than 2,400% year to date by early July. And the stock is still up

The Dow Jones Industrial Average -- the iconic 30-company stock average that is the oldest index still in use today -- is getting an adjustment. In a recent note, the division of S&P Global (NYSE:

Tesla (NASDAQ: TSLA) jumped on the stock-splitting bandwagon recently. Following a similar move from iPhone maker Apple (NASDAQ: AAPL), Tesla decided to split its shares 5-for-1. The stock has

The Dow Jones Industrial Average (DJINDICES: ^DJI)  is getting its biggest shakeup in seven years, announcing a trio of moves including swapping out aerospace specialist Raytheon Technologies (NYSE:

The COVID-19 pandemic has unleashed an economic malaise the likes of which we have not witnessed since the Great Recession in 2008 and 2009. Entire industries such as airlines and hotels are feeling

"We will go for regulatory approvals in October." 

Those were the words of Pfizer (NYSE: PFE) CEO Albert Bourla in a Washington Post live interview earlier this month. He was referring to the

This has been a wild year for Wall Street. The unprecedented coronavirus disease 2019 (COVID-19) pandemic initially pushed equities to their fastest and steepest bear market decline in history, with

For more than a decade, solar has been one of the highest-potential growth opportunities in the energy sector. That's worked out well for some companies and ended badly for others, but amid the

The S&P 500 is once again trading around all-time highs, despite the ongoing coronavirus pandemic and recession. But not every company will manage to ride the wave higher. Here are two stocks that